Bharat Biotech said on Wednesday it had submitted data from its COVID-19 vaccine trial in children aged 2 to 18 years to India's drug regulator, becoming the country's first company to have tested its shot in very young children.
The South Asian country is turning its focus towards vaccinating children against the coronavirus, having already administered more than 920 million doses to adults among its population of nearly 1.4 billion.
India's drug regulator last month allowed vaccine maker Serum Institute to enroll kids aged 7 to 11 years for its trial of U.S. drugmaker Novavax's
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
India to pay more than $300 million to next of kin of Covid-19 victimsIndia's top court on Monday approved the government's decision to pay about $670 for every coronavirus death in the country as compensation to the next of kin of the deceased.
Read more »
India asks Coal India to invest in electric vehicles, charging podsIndia's coal ministry has asked state-run Coal India to diversify its interests to areas such as electric vehicles and charging stations, according to an agenda document on the ministry's website.
Read more »
India spotlights Facebook’s ubiquity problemThe social network and its WhatsApp platform are proxies for the internet and phone in the $920 bln company’s biggest market. So their outage had users scrambling. That’s New Delhi’s cue to extend its aggressive effort to curb Facebook’s heft beyond simply policing content.
Read more »
Inaccurate, Sensational Media Coverage Contributes to Abortion Stigma in India - Women’s Media CenterAbortion has been legal in India for the past 50 years, and a recent amendment to the abortion law expanded the circumstances for legal abortion, but it remains largely stigmatized in Indian society.
Read more »
Johnson & Johnson Submits Booster Shot Data To FDA For ApprovalThe company has released data suggesting the second shot offers strong protection against Covid-19.
Read more »
AstraZeneca Seeks Emergency Use Authorization In U.S. For Covid Prophylaxis DrugLate-stage trials of the drug show it is 77% effective in reducing the risk of Covid-19 symptoms if administered as a preventive treatment.
Read more »